Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 5, 2005, Pages 519-524

  D'Souza, R F C ^a,b   Feakins, R ^b   Mears, L ^b   Sabin, C A ^c   Foster, G R ^a  

^a Institute of Cell and Molecular Science   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BASAL METABOLIC RATE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE TOLERANCE; HEPATITIS C; HUMAN; HUMAN TISSUE; IRON STORAGE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 15044365203     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02382.x     Document Type: Article

References (29)

1. WHO. Global surveillance and control of hepatitis C. J Viral Hep 1999; 6: 35-47.
2. Seeff L. Natural history of chronic hepatitis C. National Institutes of Health Consensus Development Conference Management of Hepatitis C: 2002. Hepatology 2002; 36: S35-46.
3. Poynard T, Bedossa P, Opolan P for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
4. Bassett S, Di Bisceglie A, Bacon B, et al. Effects of iron on hepatitis C in Chimpanzees examined. Hepatology 1999; 29: 1884-92.
5. Bonkovsky H, Banner B, Rothman A. Iron and chronic viral hepatitis. Hepatology 1997; 27: 759-68.
6. Di Bisceglie A, Axiotis C, Hoofnagle J, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-13.
7. Haque S, Chandra B, Gerber M, et al. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996; 27: 1277-81.
8. Thorburn D, Curry G, Spooner R, et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002; 50: 248-52.
9. Metwally M, Zein C, Zein N. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J of Gastroenterol 2004; 99: 286-91.
10. Allison M, Wreghitt T, Palmer C, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
11. Mehta S, Brancati F, Sulkowski M, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
12. Knobler H, Schihmanter R, Zifroni A, et al. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-9.
13. Alexander G. An association between hepatitis C virus infection and type 2 diabetes mellitus: what is the connection? Ann Intern Med 2000; 133: 650-2.
14. Ford E, Cogswell M. Diabetes and serum ferritin concentration among US adults. Diabetes Care 1999; 22: 1978-83.
15. Paris R. Association of hepatitis C and Diabetes Mellitus. Ann Intern Med 2001; 135: 141-2.
16. Furantani M, Nakashima T, Sumida Y, et al. Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection. Liver Int 2003; 23: 294-9.
17. Ishak K, Bapista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
18. Piperno A, Vergani A, Malosio I, et al. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE mutations. Hepatology 1998; 28: 1105-9.
19. Tung B, Kowdley K. Iron and viral hepatitis. Viral Hepat Rev 1999; 5: 63-76.
20. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, et al. The relation of iron status and haemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999; 116: 127-34.
21. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 1975; 68: 525-33.
22. Ioannou G, Dominitz J, Weiss N, et al. Racial differences in the relationship between hepatitis C infection and iron stores. Hepatology 2003; 37: 795-801.
23. Ioannou G, Dominitz J, Weiss N, et al. The effects of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anaemia. Gastroenterology 2004; 126: 1293-301.
24. Labropoulou-Karatza C, Goritsas C, Fragopanagou H, et al. High prevalence of diabetes mellitus among adult beta-thalassaemic patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 1999; 11: 1033-6.
25. Searle J, Kerr J, Halliday J, et al. Iron storage disease. In: MacSween, R, et al. eds. Pathology of the Liver, 3rd edn. Edinburgh: Churchill Livingstone, 1994: 1439-89.
26. Sanyal A, Contos M, Sterling R, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 2003; 98: 2064-71.
27. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-48.
28. Aytug S, Reich D, Sapiro L, et al. Impaired IRS-1/P13-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384-92.
29. Monto A, Alonzo J, Watson J, et al. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 2002; 36: 729-36.